Bayer Aktiengesellschaft remains undervalued despite a strong 18-month rally and ongoing operational improvements. I see upside potential supported by improving EBIT, robust pipeline assets, and technical breakout, though litigation and high debt persist. Litigation settlements and negative free cash flow weigh on the balance sheet, but recent Apollo investment and restructuring efforts provide some relief.

seekingalpha.com - 2026-07-13 09:38:56

The asset-management firm agreed to buy a minority stake in Bayer's long-acting reversible contraceptives business.

wsj.com - 2026-07-10 02:45:00

Bayer said on Friday it had secured €3 ​billion ($3.4 billion) in equity from ‌Apollo-managed funds in a deal tied to its long-acting reversible contraceptives, or LARC, business, ​aiming to bolster its capital ​structure while preserving control.

reuters.com - 2026-07-10 02:33:42

June 30 (Reuters) - Bayer asked ​Washington to impose duties on glyphosate, the chemical used in the company's weedkiller Roundup, ‌imported from China, saying it was being sold at artificially low prices.

reuters.com - 2026-06-30 20:24:00

Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology candidate. How do their financials and risk profiles stack up?

fool.com - 2026-06-30 07:45:03

Bayer shares jump 17% after a Supreme Court ruling on Roundup litigation that could significantly reduce warning-based claims and litigation costs.

zacks.com - 2026-06-26 11:06:08

A high-court victory gives the German company more leverage to settle outstanding cases.

wsj.com - 2026-06-26 10:00:00

Bayer (BAYRY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

zacks.com - 2026-06-26 09:45:34

Bayer AG S/ADR by Bayer AG (OTCQX:BAYRY) shares are jumping on Thursday. The U.S. Supreme Court delivered a major legal win for the company in long‑running Roundup litigation.

benzinga.com - 2026-06-25 12:56:30

The court ruled that states cannot have differing labeling warning rules than federal law requires.

marketwatch.com - 2026-06-25 11:31:00

The Supreme Court in a 7-2 decision on Thursday said Bayer cannot be sued over state-level claims that the company failed to warn of cancer risks from its weedkiller Roundup and its chemical glyphosate. The decision is a major win for Bayer, which bought Roundup maker Monsanto in 2018, and the Trump administration, which argued that failure-to-warn claims were preempted by a separate federal law that governs pesticides.

cnbc.com - 2026-06-25 11:05:22

The Supreme Court ruled in favor of former agrochemical giant Monsanto on Thursday in a dispute over whether the company should have warned consumers about potential harms arising from its weed killer product Roundup, in a 7-2 ruling that led shares of parent company Bayer to spike Thursday morning.

forbes.com - 2026-06-25 10:45:10

Here is how Bayer Aktiengesellschaft (BAYRY) and Cardinal Health (CAH) have performed compared to their sector so far this year.

zacks.com - 2026-06-25 10:41:19

Shares in Germany's Bayer surged ​by the most ‌in 23 years on Thursday after the ​U.S. Supreme Court ​sided with the the ⁠company concerning lawsuits ​related its Roundup weedkiller.

reuters.com - 2026-06-25 10:28:13

The decision will help the company in its bid to resolve thousands of claims that the popular weedkiller caused cancer.

wsj.com - 2026-06-25 10:11:00

CALGARY, Alberta--(BUSINESS WIRE)--The Crop Science division of Bayer announced that Kacy Perry has been appointed the Country Division Head (CDH) for Crop Science Canada, effective July 1. In this role, she will lead 550+ employees working at multiple sites across Canada and serves as a member of Bayer's North American Leadership Team for Crop Science. Perry currently serves as the North America Soybean Business Lead for Bayer's Crop Science division and has been with Bayer for the entirety of.

businesswire.com - 2026-06-18 15:22:00

A federal judge on ‌Wednesday returned Bayer's proposed $7.25 billion settlement of Roundup lawsuits to Missouri state court, overruling the ​objections of some cancer victims who ​said the state court could not ⁠bind a nationwide class of people ​who allege that the popular weedkiller caused ​their cancer.

reuters.com - 2026-06-17 11:17:09

Bayer (BAYRY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

zacks.com - 2026-06-15 13:01:08

BAYRY's asundexian enters EMA review for stroke prevention after phase III data showed a 26% cut in ischemic stroke without more major bleeding.

zacks.com - 2026-06-11 11:22:12

Bayer is hoping to speed up a plan to facilitate North American production of biofuel feedstocks like camelina in the wake of the Iran ​war, the drug-making and crop science giant said on Wednesday.

reuters.com - 2026-06-10 13:43:58

Investors with an interest in Large Cap Pharmaceuticals stocks have likely encountered both Bayer Aktiengesellschaft (BAYRY) and Roche Holding AG (RHHBY). But which of these two stocks presents investors with the better value opportunity right now?

zacks.com - 2026-06-08 12:41:07

BASEL, Switzerland & WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced leadership changes within its Consumer Health division to accelerate growth, strengthen commercial execution, and further enhance speed of decision making. These changes reflect the company's commitment to continuously adapt and advance its Road to Billions strategy aimed at helping billions of people live healthier lives.

businesswire.com - 2026-06-08 08:00:00

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer Summary Bayer announced today full results from the Phase III FIND-CKD trial investigating KERENDIA® (finerenone) in adults with non-diabetic chronic kidney disease (nd-CKD) who were also receiving background standard of care. In the trial, KERENDIA met the primary endpoint by showing a significant reduction in the rate of kidney disease progression, as measured by estimated glomerular filtration rate (eGFR) slope (mean annual change from baseline to month.

businesswire.com - 2026-06-05 06:40:00

Bayer rules out a Monsanto spin-off despite mounting Roundup lawsuits that continue to pressure the company.

feeds.benzinga.com - 2026-06-03 04:32:17

Bayer has no plans to spin off Monsanto, a representative said on Tuesday, ‌even as the company faces an avalanche of lawsuits over its Roundup weedkiller.

reuters.com - 2026-06-02 19:11:20

WHIPPANY, N.J.--(BUSINESS WIRE)--Primary results from the Phase II ARACOG (AFT-47) trial, a head-to-head randomized trial conducted by Alliance Foundation Trials LLC, showed that patients treated with NUBEQA® (darolutamide; n=55) experienced significantly less decline in objective cognitive performance over 24 weeks compared with those treated with enzalutamide (n=56).

businesswire.com - 2026-05-30 17:24:00

Bayer used illegal and anti-competitive practices to monopolize the U.S. market for genetically engineered corn seeds, reaping "hundreds of millions, if not ​billions, of ill-gotten dollars," according to a federal lawsuit that adds to legal troubles plaguing the Germany-based company.

reuters.com - 2026-05-27 17:54:07

In the Large-Cap Pharmaceuticals industry, LLY, J&J, NVO and BAYRY are worth retaining as the industry shows some recovery.

zacks.com - 2026-05-26 09:51:06

Bayer wins FDA Priority Review for Kerendia label expansion in CKD tied to type I diabetes after strong phase III data.

zacks.com - 2026-05-21 14:00:24

Bayer said on Thursday that ​the U.S. Food and ‌Drug Administration had accepted its supplemental ​New Drug Application ​for finerenone and granted ⁠priority review designation.

reuters.com - 2026-05-21 02:56:31

Investors interested in Large Cap Pharmaceuticals stocks are likely familiar with Bayer Aktiengesellschaft (BAYRY) and Roche Holding AG (RHHBY). But which of these two companies is the best option for those looking for undervalued stocks?

zacks.com - 2026-05-20 12:40:24

BAYRY wins FDA priority review for sevabertinib in first-line HER2-mutant NSCLC, building momentum for the oral TKI.

zacks.com - 2026-05-19 12:06:10

BAYRY gains FDA Priority Review for asundexian NDA after phase III data showed a 26% cut in ischemic stroke risk without more major bleeding.

zacks.com - 2026-05-19 11:30:13

Bayer's Monsanto unit on Monday said it ​would pay at least $133 million to settle Michigan and Rhode Island's claims that the company ‌contaminated the states' natural resources with toxic chemicals that are known to have dangerous health effects.

reuters.com - 2026-05-18 15:39:46

Bayer Aktiengesellschaft ETR: BAYN executives said the company's Crop Science division remains on track with a five-year plan centered on cost savings, margin expansion and a slate of product launches in seeds, traits and crop protection.

marketbeat.com - 2026-05-14 12:16:18

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer and country superstar and five-time Entertainer of the Year Luke Bryan today launched their 2026 campaign to expand access to food and nutrition in rural America, with Bayer donating 1 million meals* through Feeding America®. The campaign kicks off May 14–16 in California with a Walmart community food drive in Clovis, followed by additional food collection at Farm Tour stops in Clovis and Elk Grove. In partnership with Central California Food Bank and Sacr.

businesswire.com - 2026-05-13 09:04:00

BAYRY beats Q1 earnings estimates as Crop Science sales rise, while Nubeqa and Kerendia gains help offset declines in Xarelto and Eylea.

zacks.com - 2026-05-12 12:26:10

Bayer Aktiengesellschaft (BAYRY) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-05-12 08:00:52

The group's net profit was aided by a gain from the sale of an antibiotics business and stronger underlying earnings at its agricultural division.

wsj.com - 2026-05-12 02:03:00

Bayer on ​Tuesday said first-quarter ‌operating profit gained 9%, ​driven mainly ​by its agricultural ⁠business.

reuters.com - 2026-05-12 01:40:20

BERLIN & WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced positive topline results from the Phase III REVEAL study, an investigator-initiated study by Brigham and Women's Hospital that evaluated the investigational PET/CT radiotracer I 124 evuzamitide.1,5 The study met the primary endpoints of sensitivity (the ability of a test to identify individuals who have the condition) and specificity (the ability of a test to identify individuals who do not have the condition) for the diagnosis of.

businesswire.com - 2026-05-07 02:30:00

ST. LOUIS--(BUSINESS WIRE)--Bayer, a life science company, and bp, a global integrated energy company, today announced that they have entered into a long-term strategic alliance to jointly scale the crop camelina, under the brand name newgold®. The alliance will commercialize camelina starting in North America. bp brings expertise in fuels and refining, while Bayer will utilize its industry leading expertise in seed technology, as well as its extensive farmer customer base. The alliance aims to.

businesswire.com - 2026-05-06 08:00:00

Bayer said on Wednesday ​new analyses ‌showed its experimental blood thinner ​asundexian reduced ​the incidence and ⁠severity of ​ischaemic strokes.

reuters.com - 2026-05-06 04:36:55

The German pharmaceutical-and-agricultural group said that the deal aims to complement its ophthalmology pipeline.

wsj.com - 2026-05-06 03:09:00

Bayer said on ​Wednesday that ‌it will buy biopharmaceutical company ​Perfuse ​Therapeutics to complement ⁠its ophthalmology ​pipeline.

reuters.com - 2026-05-06 02:45:05

BERLIN & SAN FRANCISCO--(BUSINESS WIRE)--Bayer and Perfuse Therapeutics Inc. today announced an agreement under which Bayer will fully acquire Perfuse Therapeutics, a biopharmaceutical company pioneering transformational research into the treatment of ischemia-induced ocular diseases. With this acquisition, Bayer will hold the full rights pertaining to PER-001, a small molecule endothelin receptor antagonist currently in Phase II clinical development for the treatment of Glaucoma and Diabetic R.

businesswire.com - 2026-05-06 02:30:00

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced that a broad set of data from its stroke franchise will be presented at the 2026 European Stroke Organisation Conference (ESOC), including new late-breaking analyses from its global, landmark Phase III OCEANIC-STROKE study of asundexian, an investigational oral Factor XIa inhibitor. In total, 13 abstracts will be presented, including four OCEANIC-STROKE sub-analyses. Additionally, Bayer will present nine real-world analyses examining stroke.

businesswire.com - 2026-04-29 08:00:00

Bayer Aktiengesellschaft (BAYRY) Shareholder/Analyst Call Transcript

seekingalpha.com - 2026-04-28 06:21:39

Shares in chemicals giant Bayer fell as ​much as 6.5% on ‌Tuesday after the U.S. Supreme Court appeared split ​over what view ​it will form in Bayer's ⁠fight against Roundup ​lawsuits.

reuters.com - 2026-04-28 03:43:23

"Make America Healthy Again" activists rallied at the U.S. Supreme Court building on ​Monday against Bayer as the justices heard arguments in the German company's effort to end thousands of lawsuits that allege ‌its weedkiller Roundup causes cancer.

reuters.com - 2026-04-27 16:09:22